优先票据发行 - Humana公司宣布发行总额为22.5亿美元的优先票据[1] - 预计从优先票据发行中获得净收益约为22.26亿美元[2] - 优先票据发行由多家投行担任联席主承销商[3] - 优先票据发行是根据有效的注册声明进行的[4] 资金用途 - Humana公司将利用优先票据发行的净收益用于一般企业用途[2] 政府监管和债务评级 - Humana公司的业务活动受到大量政府监管[13] - Humana公司的债务评级下调可能会对其业务、运营结果和财务状况产生不利影响[20]

In the latest trading session, Humana (HUM) closed at $339.08, marking a +0.34% move from the previous day. The stock's change was less than the S&P 500's daily gain of 0.51%. Meanwhile, the Dow gained 0.2%, and the Nasdaq, a tech-heavy index, added 0.58%.The health insurer's stock has dropped by 7.76% in the past month, falling short of the Medical sector's gain of 2.54% and the S&P 500's gain of 2.94%.The investment community will be closely monitoring the performance of Humana in its forthcoming earnings ...

Humana Inc. (HUM) recently unveiled a value-based care multi-state deal with the renowned U.S. kidney care provider, Strive Health. It did so in a bid to offer relief for the health insurer’s Medicare Advantage HMO and PPO plan members suffering from chronic kidney disease or end-stage kidney disease.The abovementioned members residing in Indiana, Illinois, Kentucky, Michigan and northwest North Carolina can presently enjoy access to the enhanced value-based kidney care delivered by Strive. To do so, Strive ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) and kidney care provider Strive Health have announced a new value-based care multi-state agreement for most Humana Medicare Advantage HMO and PPO plan members who live with kidney disease. Value-based care is a holistic, patient-centered healthcare model that focuses on a coordinated effort to help improve patient health outcomes and quality of life. With this agreement, members with chronic kidney disease and ...

公司股价表现 - Humana (HUM) 最近的股价为 $350.32，较前一个交易日下跌了 -0.24% [1] - 过去一个月，该公司的股价下跌了 7.12%，表现不如医疗行业的增长 5.15% 和标普500指数的增长 3.85% [2] 财务表现预测 - 预计Humana将报告每股收益为 $6.49，同比下降了 30.81%。同时，最新的共识估计预计收入为 $28.53亿，较去年同期增长了 6.69% [3] - 根据Zacks Consensus Estimates，整年的预计每股收益为 $17.28，收入为 $112.31亿，较上一年分别下降了 -33.77% 和增长了 +8.27% [4] 分析师评级和行业比较 - 最近对Humana的分析师预测发生了变化，这些调整通常反映了短期业务模式的变化。因此，预测的积极变化表明分析师对公司的业务健康和盈利能力持乐观态度 [5] - Zacks Rank系统从 1（强热门）到 5（强卖出）的范围内，经过第三方审计验证，股票评级为 1 的股票自1988年以来的平均年回报率为 +25%。目前，Humana的Zacks Rank为 5（强卖出） [7] 行业比较和展望 - 投资者应注意，Humana目前的前瞻市盈率为 20.32，较行业的前瞻市盈率 17.02 有溢价 [7] - 投资者还应注意，HUM目前的PEG比率为 1.91。与被广泛接受的市盈率相似，PEG比率也考虑了公司的预期盈利增长。昨日收盘价下，医疗-HMOs行业的平均PEG比率为 1.09 [8] - 医疗-HMOs行业属于医疗行业。该行业的Zacks Industry Rank为 228，属于所有250+行业中的后10% [9] - Zacks Industry Rank按照每个行业内各个公司的平均Zacks Rank从好到坏排序。我们的研究显示，评级排名前50%的行业的表现比后50%的行业好一倍 [10]

Humana Inc. (HUM) recently announced its strategic partnership with Veda, which is aimed at solving provider data challenges. Veda will aid Humana in improving the accuracy of provider information and helping seniors get real-time details of in-network providers. This will help seniors gain access to high-quality health services and improve customer satisfaction as a result.This move bodes well for Humana as it spends a good chunk of time in calls to confirm provider data. Inaccurate and inconsistent data f ...

LOUISVILLE, Ky. & MADISON, Wis.--(BUSINESS WIRE)--Leading health and well-being company Humana Inc. (NYSE: HUM) today announced a strategic partnership with Veda, a health technology company specializing in helping healthcare companies solve complex provider data challenges. Humana will partner with Veda to improve the accuracy of its provider information and ensure that seniors have real-time details about in-network providers, making it easier for them to access high-quality healthcare. Ensuring the accu ...

Users can choose the method they prefer when requesting a prescription with the new, user-friendly CenterWell Pharmacy mobile app. (Graphic: Business Wire)LOUISVILLE, Ky.--(BUSINESS WIRE)--CenterWell Pharmacy® has introduced a new mobile app that lets customers manage their prescriptions anytime and anywhere, requesting refills, shopping for over-the-counter products, tracking orders and more. Thanks to a total redesign and increased personalization capabilities, the new CenterWell Pharmacy app streamlin ...

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Bruce D. Broussard, Chief Executive Officer, and Susan M. Diamond, Chief Financial Officer, will make a presentation to investors at TD Cowen’s 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 9:10 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana’s Investor Relations page at humana.com. The company suggests webcast participants sign on approximately 15 minutes in advance of ...

可口可乐财报分析 - 可口可乐第四季度财报表现不佳，销售量下降导致股价下滑[4] - 可口可乐在北美地区的销售量下降，但通过提高价格部分抵消了影响[6] - 可口可乐预计外汇汇率将对全年收入和利润产生影响[6] Humana财务状况分析 - 人寿保险公司Humana发布意外亏损的第四季度财报，未来展望不乐观[8] - Humana在Medicare Advantage计划上的投资增加了成本，导致公司财务压力增大[11] AT&T财务表现分析 - 电信巨头AT&T的第四季度财报表现不佳，股价下跌[12] - AT&T的固定电话业务销售额下降，股价长期走低[13]